首页 › 基金 › Venrock Adviser, LLC › VRDN

Venrock Adviser, LLC 对 VRDN 的持仓历史

VIRIDIAN THERAPEUTICS INC · 医疗保健

Venrock Adviser, LLC 在 Q3 2026 的 13F 申报中披露持有 VRDN(VIRIDIAN THERAPEUTICS INC)3,257,917 股,市值约 US$67.1M,约占其申报组合的 3.26%,在其申报持仓中市值排名第 9 位。 Venrock Adviser, LLC 最近 13 个申报季度中有 13 个季度披露了 VRDN 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q3 2026)3.26M 股
申报持仓市值$67.08M
组合权重3.26%
首次申报Q3 2023
最近变动持有
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

Venrock Adviser, LLC 对 VRDN 的持仓演变

Venrock Adviser, LLC 于 Q3 2023 首次披露 VRDN 持仓:3,082,622 股(约 US$47.3M)。 该持仓在 Q4 2025 达到峰值 3,882,709 股,市值约 US$120.8M。 在 13 次申报中,Venrock Adviser, LLC 1 次增持、1 次减持、10 次保持不变。 最近一期申报(Q3 2026)显示持股 3,257,917 股、市值约 US$67.1M。 持仓曾出现大幅变动:Q4 2023 增持约 26% (随后一个季度股价下跌 20%)。

逐季持仓明细

季度股数金额变化
Q3 2023 3.08M $47.29M 新进
Q4 2023 3.88M $84.56M 增持
Q1 2024 3.88M $67.99M 持有
Q2 2024 3.88M $50.51M 持有
Q3 2024 3.88M $88.33M 持有
Q4 2024 3.88M $74.43M 持有
Q1 2025 3.88M $52.34M 持有
Q2 2025 3.88M $54.28M 持有
Q3 2025 3.88M $83.79M 持有
Q4 2025 3.88M $120.83M 持有
Q1 2026 3.88M $75.95M 持有
Q2 2026 3.26M $59.85M 减持
Q3 2026 3.26M $67.08M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 VRDN 与 13F 数据

VRDN(VIRIDIAN THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 40 只申报持有 VRDN,申报仓位最大的包括:Paradigm Biocapital Advisors LP (US$227.1M), Bellevue Group AG (US$146.4M), Kynam Capital Management, LP (US$126.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 VRDN 的基金

查看 VRDN 的全部基金持有人 →

常见问题

How long has Venrock Adviser, LLC held VRDN?

Venrock Adviser, LLC has disclosed VRDN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Venrock Adviser, LLC's current position in VRDN?

As of Q3 2026, Venrock Adviser, LLC holds 3.26M shares of VRDN (VIRIDIAN THERAPEUTICS INC), valued at $67.08M, representing 3.26% of its reported portfolio and ranking #9.

Has Venrock Adviser, LLC been buying or selling VRDN?

In the latest 13F filing (Q3 2026), Venrock Adviser, LLC held unchanged its position in VRDN. The position peaked in Q4 2025 at 3.88M shares.

Which other funds hold VRDN?

Other major institutional holders of VRDN include Paradigm Biocapital Advisors LP, Bellevue Group AG, Kynam Capital Management, LP, among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.